Arash Rafii

Weill Cornell Medicine Qatar

Dr. Rafii received an M.D. from the Université Paris V René Descartes and a Ph.D. in Molecular Oncology from the Université Paris XI, Kremelin Bicetre. Subsequently, he was a resident in Gynecology-Obstetrics at the Assistance Public-Hopitaux de Paris and a Fellow in Gynecologic Oncology at the Institut Claudius Regaud, Toulouse. Additional academic positions held by Dr. Rafii include Research Fellow at Washington University, St. Louis, Assistant Professor at the Université Paul Sabatier, Toulouse, and Junior Faculty member at INSERM, U872, Paris. From 2007 to 2008, he was an attending physician in Gynecologic Oncology at the Institut Claudius Regaud, Toulouse, France. Dr. Rafii's research focuses on stem cell science and gynecologic oncology, in particular the role of the interaction between mesenchymal stem cells and cancer cells in the acquisition of chemoresistance. At Weill Cornell Medicine - Q (WCM-Q), his research focuses on ovarian cancer and stem cell biology. Through collaboration with WCMC Department of Genetic Medicine as well as the Ansary Stem Cell Center for Regenerative Medicine, his laboratory uses a system biology approach to stroma mediated cancer resistance as well as to organ regeneration. He has also set up s specific program to investigate the use of Next gene sequencing platforms to set up a personalized medicine approach to advanced cancers. In this program his group is investigating notions such as cancer heterogeneity during metastatic spread and tailored targeted therapy in advanced cancer.